Marathon Trading Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$231K Buy
+1,921
New +$222K 0.01% 171
2025
Q4
Sell
-15,121
Closed -$1.27M 384
2025
Q3
$1.27M Sell
15,121
-18,100
-54% -$1.49M 0.09% 98
2025
Q2
$2.63M Buy
33,221
+32,951
+12,204% +$2.62M 0.31% 58
2025
Q1
$24.2K Sell
270
-2,430
-90% -$227K ﹤0.01% 319
2024
Q4
$269K Sell
2,700
-1,612
-37% -$166K 0.01% 191
2024
Q3
$490K Buy
4,312
+3,682
+584% +$437K 0.04% 147
2024
Q2
$78K Buy
+630
New +$81.2K 0.01% 227
2023
Q2
Sell
-128
Closed -$14.5K 295
2023
Q1
$13.6K Buy
+128
New +$13.8K ﹤0.01% 240
2019
Q2
Sell
-28,401
Closed -$2.25M 262
2019
Q1
$2.25M Buy
+28,401
New +$2.12M 0.26% 79
2015
Q1
Sell
-31,650
Closed -$1.72M 562
2014
Q4
$1.72M Buy
+31,650
New +$1.76M 0.02% 277

Other funds holding MRK

Marathon Trading Investment Management's MRK Position: Q1 2026 in Review

Marathon Trading Investment Management opened a new position in Merck (MRK) in Q1 2026: 1,921 shares worth $231K. The stake represents 0.01% of the portfolio and ranks #171 among its holdings. This is a return to the name: Marathon Trading Investment Management previously reported a position in MRK as recently as Q3 2025.

Marathon Trading Investment Management first reported a position in MRK in Q4 2014 and has held it in 10 quarters since. The position peaked at $2.63M in Q2 2025. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Marathon Trading Investment Management held 1,921 shares of Merck worth $231K as of Q1 2026.
  • Merck was a new Marathon Trading Investment Management position in Q1 2026.
  • Merck made up 0.01% of Marathon Trading Investment Management's portfolio in Q1 2026, its #171 holding.
  • Marathon Trading Investment Management first reported a position in Merck in Q4 2014 and has held it in 10 quarters since.
  • Marathon Trading Investment Management's Merck position peaked at $2.63M in Q2 2025.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Marathon Trading Investment Management's 13F filing for Q1 2026, filed 14 May 2026.